A systematic review of the effectiveness of policies restricting access to pregabalin
Crossref DOI link: https://doi.org/10.1186/s12913-017-2503-x
Published Online: 2017-08-25
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Stacey, Brett R.
Liss, Jonathan
Behar, Regina
Sadosky, Alesia
Parsons, Bruce
Masters, Elizabeth T.
Hlavacek, Patrick
Funding for this research was provided by:
Pfizer